Joyce Lee - Zoetis President

ZTS -- USA Stock  

Quarterly Earning Report: November 7, 2019  

Ms. Joyce J. Lee serves as Executive Vice President Area President of the Canada and Latin America region of Zoetis Inc. Ms. Lee was Area President of the same region for Pfizer Animal Health from 2010 to 2012
Age: 41  President Since 2012      
973 822-7000
Lee joined Pfizer in 2003 with its acquisition of Pharmacia and held various positions, including Vice President of Global Poultry and Vice President of Global Business Technology, for Pfizer Animal Health.

Joyce Lee Latest Insider Activity

Management Efficiency

The company has Return on Asset of 12.56 % which means that on every $100 spent on asset it made $12.56 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 62.6 % implying that it generated $62.6 on every 100 dollars invested.
The company has 6.65 B in debt with debt to equity (D/E) ratio of 275.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.09 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Showing few of many executives


Ronald JanishPerrigo Company Plc
Peter PowchikRegeneron Pharmaceuticals
John GrayVertex Pharmaceuticals Incorpor
Douglas BoothePerrigo Company Plc
Cartikeya ReddyDr Reddys Laboratories Ltd
Jay MarkowitzRegeneron Pharmaceuticals
Samiran DasDr Reddys Laboratories Ltd
Daniel PlewRegeneron Pharmaceuticals
Sripada ChandrasekharDr Reddys Laboratories Ltd
Jatin ShahPerrigo Company Plc
Michael PariniVertex Pharmaceuticals Incorpor
J RamachandranDr Reddys Laboratories Ltd
Ian SmithVertex Pharmaceuticals Incorpor
Saumen ChakrabortyDr Reddys Laboratories Ltd
Amit BiswasDr Reddys Laboratories Ltd
Thomas FarringtonPerrigo Company Plc
John HendricksonPerrigo Company Plc
Svend AndersenPerrigo Company Plc
Charles WagnerVertex Pharmaceuticals Incorpor
Douglas McCorkleRegeneron Pharmaceuticals
K RaoDr Reddys Laboratories Ltd

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Current Sentiment - ZTS

Zoetis Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Zoetis. What is your take regarding investing in Zoetis? Are you bullish or bearish?
98% Bullish
2% Bearish

Also Currentnly Active

Purchased few shares of
a day ago
Traded for 177.06
Purchased over 300 shares of
a day ago
Traded for 8.78
Purchased over 70 shares of
a day ago
Traded for 35.57
See also Your Current Watchlist. Please also try Chance of Distress module to get analysis of equity chance of financial distress in the next 2 years.